Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone

Georgina Harris, Melanie Eschment, Sebastian Perez Orozco, J. Michael McCaffery, Richard Maclennan, Daniel Severin, Marcel Leist, Andre Kleensang, David Pamies, Alexandra Maertens, Helena Hogberg, Dana Freeman, Alfredo Kirkwood, Thomas Hartung, Lena Smirnova

Research output: Contribution to journalArticle

Abstract

To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrations. This testing strategy does not reflect real-life exposures, which might contribute to long-term disease outcome. We used a 3D-human dopaminergic in vitro LUHMES cell line model to determine whether effects of short-term rotenone exposure (100 nM, 24 h) are permanent or reversible. A decrease in complex I activity, ATP, mitochondrial diameter, and neurite outgrowth were observed acutely. After compound removal, complex I activity was still inhibited; however, ATP levels were increased, cells were electrically active and aggregates restored neurite outgrowth integrity and mitochondrial morphology. We identified significant transcriptomic changes after 24 h which were not present 7 days after wash-out. Our results suggest that testing short-term exposures in vitro may capture many acute effects which cells can overcome, missing adaptive processes, and long-term mechanisms. In addition, to study cellular resilience, cells were re-exposed to rotenone after wash-out and recovery period. Pre-exposed cells maintained higher metabolic activity than controls and presented a different expression pattern in genes previously shown to be altered by rotenone. NEF2L2, ATF4, and EAAC1 were downregulated upon single hit on day 14, but unchanged in pre-exposed aggregates. DAT and CASP3 were only altered after re-exposure to rotenone, while TYMS and MLF1IP were downregulated in both single-exposed and pre-exposed aggregates. In summary, our study shows that a human cell-based 3D model can be used to assess cellular adaptation, resilience, and long-term mechanisms relevant to neurodegenerative research.

Original languageEnglish (US)
Pages (from-to)1-20
Number of pages20
JournalArchives of Toxicology
DOIs
StateAccepted/In press - Jun 28 2018

Fingerprint

Rotenone
Toxicity
Recovery
Testing
Adenosine Triphosphate
Cells
Down-Regulation
Caspase 3
Genes
In Vitro Techniques
Cell Line
Research

Keywords

  • 3D LUHMES
  • Cellular defence
  • Gene response
  • Neurodegeneration
  • Pesticide
  • Recovery
  • Resilience
  • Rotenone

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone. / Harris, Georgina; Eschment, Melanie; Orozco, Sebastian Perez; McCaffery, J. Michael; Maclennan, Richard; Severin, Daniel; Leist, Marcel; Kleensang, Andre; Pamies, David; Maertens, Alexandra; Hogberg, Helena; Freeman, Dana; Kirkwood, Alfredo; Hartung, Thomas; Smirnova, Lena.

In: Archives of Toxicology, 28.06.2018, p. 1-20.

Research output: Contribution to journalArticle

Harris, Georgina ; Eschment, Melanie ; Orozco, Sebastian Perez ; McCaffery, J. Michael ; Maclennan, Richard ; Severin, Daniel ; Leist, Marcel ; Kleensang, Andre ; Pamies, David ; Maertens, Alexandra ; Hogberg, Helena ; Freeman, Dana ; Kirkwood, Alfredo ; Hartung, Thomas ; Smirnova, Lena. / Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone. In: Archives of Toxicology. 2018 ; pp. 1-20.
@article{a18b54d9a6604404ac3e0b3fc6642b17,
title = "Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone",
abstract = "To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrations. This testing strategy does not reflect real-life exposures, which might contribute to long-term disease outcome. We used a 3D-human dopaminergic in vitro LUHMES cell line model to determine whether effects of short-term rotenone exposure (100 nM, 24 h) are permanent or reversible. A decrease in complex I activity, ATP, mitochondrial diameter, and neurite outgrowth were observed acutely. After compound removal, complex I activity was still inhibited; however, ATP levels were increased, cells were electrically active and aggregates restored neurite outgrowth integrity and mitochondrial morphology. We identified significant transcriptomic changes after 24 h which were not present 7 days after wash-out. Our results suggest that testing short-term exposures in vitro may capture many acute effects which cells can overcome, missing adaptive processes, and long-term mechanisms. In addition, to study cellular resilience, cells were re-exposed to rotenone after wash-out and recovery period. Pre-exposed cells maintained higher metabolic activity than controls and presented a different expression pattern in genes previously shown to be altered by rotenone. NEF2L2, ATF4, and EAAC1 were downregulated upon single hit on day 14, but unchanged in pre-exposed aggregates. DAT and CASP3 were only altered after re-exposure to rotenone, while TYMS and MLF1IP were downregulated in both single-exposed and pre-exposed aggregates. In summary, our study shows that a human cell-based 3D model can be used to assess cellular adaptation, resilience, and long-term mechanisms relevant to neurodegenerative research.",
keywords = "3D LUHMES, Cellular defence, Gene response, Neurodegeneration, Pesticide, Recovery, Resilience, Rotenone",
author = "Georgina Harris and Melanie Eschment and Orozco, {Sebastian Perez} and McCaffery, {J. Michael} and Richard Maclennan and Daniel Severin and Marcel Leist and Andre Kleensang and David Pamies and Alexandra Maertens and Helena Hogberg and Dana Freeman and Alfredo Kirkwood and Thomas Hartung and Lena Smirnova",
year = "2018",
month = "6",
day = "28",
doi = "10.1007/s00204-018-2250-8",
language = "English (US)",
pages = "1--20",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone

AU - Harris, Georgina

AU - Eschment, Melanie

AU - Orozco, Sebastian Perez

AU - McCaffery, J. Michael

AU - Maclennan, Richard

AU - Severin, Daniel

AU - Leist, Marcel

AU - Kleensang, Andre

AU - Pamies, David

AU - Maertens, Alexandra

AU - Hogberg, Helena

AU - Freeman, Dana

AU - Kirkwood, Alfredo

AU - Hartung, Thomas

AU - Smirnova, Lena

PY - 2018/6/28

Y1 - 2018/6/28

N2 - To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrations. This testing strategy does not reflect real-life exposures, which might contribute to long-term disease outcome. We used a 3D-human dopaminergic in vitro LUHMES cell line model to determine whether effects of short-term rotenone exposure (100 nM, 24 h) are permanent or reversible. A decrease in complex I activity, ATP, mitochondrial diameter, and neurite outgrowth were observed acutely. After compound removal, complex I activity was still inhibited; however, ATP levels were increased, cells were electrically active and aggregates restored neurite outgrowth integrity and mitochondrial morphology. We identified significant transcriptomic changes after 24 h which were not present 7 days after wash-out. Our results suggest that testing short-term exposures in vitro may capture many acute effects which cells can overcome, missing adaptive processes, and long-term mechanisms. In addition, to study cellular resilience, cells were re-exposed to rotenone after wash-out and recovery period. Pre-exposed cells maintained higher metabolic activity than controls and presented a different expression pattern in genes previously shown to be altered by rotenone. NEF2L2, ATF4, and EAAC1 were downregulated upon single hit on day 14, but unchanged in pre-exposed aggregates. DAT and CASP3 were only altered after re-exposure to rotenone, while TYMS and MLF1IP were downregulated in both single-exposed and pre-exposed aggregates. In summary, our study shows that a human cell-based 3D model can be used to assess cellular adaptation, resilience, and long-term mechanisms relevant to neurodegenerative research.

AB - To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrations. This testing strategy does not reflect real-life exposures, which might contribute to long-term disease outcome. We used a 3D-human dopaminergic in vitro LUHMES cell line model to determine whether effects of short-term rotenone exposure (100 nM, 24 h) are permanent or reversible. A decrease in complex I activity, ATP, mitochondrial diameter, and neurite outgrowth were observed acutely. After compound removal, complex I activity was still inhibited; however, ATP levels were increased, cells were electrically active and aggregates restored neurite outgrowth integrity and mitochondrial morphology. We identified significant transcriptomic changes after 24 h which were not present 7 days after wash-out. Our results suggest that testing short-term exposures in vitro may capture many acute effects which cells can overcome, missing adaptive processes, and long-term mechanisms. In addition, to study cellular resilience, cells were re-exposed to rotenone after wash-out and recovery period. Pre-exposed cells maintained higher metabolic activity than controls and presented a different expression pattern in genes previously shown to be altered by rotenone. NEF2L2, ATF4, and EAAC1 were downregulated upon single hit on day 14, but unchanged in pre-exposed aggregates. DAT and CASP3 were only altered after re-exposure to rotenone, while TYMS and MLF1IP were downregulated in both single-exposed and pre-exposed aggregates. In summary, our study shows that a human cell-based 3D model can be used to assess cellular adaptation, resilience, and long-term mechanisms relevant to neurodegenerative research.

KW - 3D LUHMES

KW - Cellular defence

KW - Gene response

KW - Neurodegeneration

KW - Pesticide

KW - Recovery

KW - Resilience

KW - Rotenone

UR - http://www.scopus.com/inward/record.url?scp=85049143580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049143580&partnerID=8YFLogxK

U2 - 10.1007/s00204-018-2250-8

DO - 10.1007/s00204-018-2250-8

M3 - Article

C2 - 29955902

AN - SCOPUS:85049143580

SP - 1

EP - 20

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

ER -